Advertisement
Screener

Intersect ENT, Inc. Investing Cash Flow

Intersect ENT, Inc. Investing Cash Flow

Intersect ENT, Inc. reported Investing Cash Flow of -$2.70 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.

Discontinued › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2022-05-04

  • Intersect ENT, Inc. net cash provided by (used in) investing activities for the quarter ending 2022-03-31 was -$2.70M, a 115.34% decline year-over-year.
  • Intersect ENT, Inc. net cash provided by (used in) investing activities for the quarter ending 2021-12-31 was -$1.42M.
  • Intersect ENT, Inc. net cash provided by (used in) investing activities for the quarter ending 2021-09-30 was $13.83M, a 56.96% decline year-over-year.
  • Intersect ENT, Inc. net cash provided by (used in) investing activities for the quarter ending 2021-06-30 was $19.15M.
  • Intersect ENT, Inc. net cash provided by (used in) investing activities for fiscal 2021 was $49.18M.
  • Intersect ENT, Inc. net cash provided by (used in) investing activities for fiscal 2020 was -$22.75M, a 220.40% decline from fiscal 2019.
  • Intersect ENT, Inc. net cash provided by (used in) investing activities for fiscal 2019 was $18.89M.
  • Intersect ENT, Inc. net cash provided by (used in) investing activities for fiscal 2018 was -$10.00M, a 208.15% decline from fiscal 2017.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2022-03-31-$2.70M
10-Q · filed 2022-05-04
-$4.13M
derived: sum of 2 quarters · filed 2022-05-04
$9.70M
derived: sum of 3 quarters · filed 2022-05-04
$28.85M
derived: sum of 4 quarters · filed 2022-05-04
2021-12-31-$1.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$12.40M
derived: sum of 2 quarters · filed 2022-03-08
$31.55M
derived: sum of 3 quarters · filed 2022-03-08
$49.18M
10-K · filed 2022-03-08
2021-09-30$13.83M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
$32.98M
derived: sum of 2 quarters · filed 2021-11-02
$50.60M
10-Q · filed 2021-11-02
$32.51M
derived: sum of 4 quarters · filed 2022-05-04
2021-06-30$19.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$36.77M
10-Q · filed 2021-08-06
$18.68M
derived: sum of 3 quarters · filed 2022-05-04
$50.82M
derived: sum of 4 quarters · filed 2022-05-04
2021-03-31$17.63M
10-Q · filed 2022-05-04
-$463.00K
derived: sum of 2 quarters · filed 2022-05-04
$31.67M
derived: sum of 3 quarters · filed 2022-05-04
-$21.51M
derived: sum of 4 quarters · filed 2022-05-04
2020-12-31-$18.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$14.04M
derived: sum of 2 quarters · filed 2022-03-08
-$39.14M
derived: sum of 3 quarters · filed 2022-03-08
-$22.75M
10-K · filed 2022-03-08
2020-09-30$32.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
-$21.05M
derived: sum of 2 quarters · filed 2021-11-02
-$4.65M
10-Q · filed 2021-11-02
$3.23M
derived: sum of 4 quarters · filed 2022-03-08
2020-06-30-$53.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
-$36.79M
10-Q · filed 2021-08-06
-$28.90M
derived: sum of 3 quarters · filed 2022-03-08
-$24.23M
derived: sum of 4 quarters · filed 2022-03-08
2020-03-31$16.40M
10-Q · filed 2021-05-10
$24.28M
derived: sum of 2 quarters · filed 2022-03-08
$28.96M
derived: sum of 3 quarters · filed 2022-03-08
$33.73M
derived: sum of 4 quarters · filed 2022-03-08
2019-12-31$7.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$12.56M
derived: sum of 2 quarters · filed 2022-03-08
$17.34M
derived: sum of 3 quarters · filed 2022-03-08
$18.89M
10-K · filed 2022-03-08
2019-09-30$4.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02
$9.46M
derived: sum of 2 quarters · filed 2020-11-02
$11.01M
10-Q · filed 2020-11-02
$13.04M
derived: sum of 4 quarters · filed 2021-03-09
2019-06-30$4.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$6.33M
10-Q · filed 2020-08-05
$8.36M
derived: sum of 3 quarters · filed 2021-03-09
$7.23M
derived: sum of 4 quarters · filed 2021-03-09
2019-03-31$1.55M
10-Q · filed 2020-05-11
$3.58M
derived: sum of 2 quarters · filed 2021-03-09
$2.45M
derived: sum of 3 quarters · filed 2021-03-09
$2.12M
derived: sum of 4 quarters · filed 2021-03-09
2018-12-31$2.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09
$898.00K
derived: sum of 2 quarters · filed 2021-03-09
$562.00K
derived: sum of 3 quarters · filed 2021-03-09
-$10.00M
10-K · filed 2021-03-09
2018-09-30-$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$1.47M
derived: sum of 2 quarters · filed 2019-11-05
-$12.03M
10-Q · filed 2019-11-05
-$11.23M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$336.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05
-$10.90M
10-Q · filed 2019-08-05
-$10.10M
derived: sum of 3 quarters · filed 2020-02-27
-$8.76M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$10.56M
10-Q · filed 2019-05-07
-$9.76M
derived: sum of 2 quarters · filed 2020-02-27
-$8.42M
derived: sum of 3 quarters · filed 2020-02-27
2017-12-31$802.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$2.14M
derived: sum of 2 quarters · filed 2020-02-27
$9.25M
10-K · filed 2020-02-27
2017-09-30$1.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
$8.45M
10-Q · filed 2018-11-05
2017-06-30$7.11M
10-Q · filed 2018-08-03
2016-12-31-$6.86M
10-K · filed 2019-02-28